The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TWT-203: Phase 1b/2 dose-confirming study of CFI-402257 as a single agent in advanced solid tumors and in combination with fulvestrant in patients with ER+/HER2- advanced breast cancer after disease progression on prior CDK4/6 and endocrine therapy.
 
Robert Wesolowski
Consulting or Advisory Role - Celcuity; Perthera
Speakers' Bureau - ONCOLIVE; Roche
Travel, Accommodations, Expenses - Roche
 
Mark R. Bray
Employment - Treadwell Therapeutics
Stock and Other Ownership Interests - Treadwell Therapeutics
 
Glenn C. Michelson
Consulting or Advisory Role - Apollomics; Black Diamond Therapeutics; Catalyst Biotech; CG Pharmaceuticals; Deciphera; Fore Biotherapeutics; Inclin; Lyvgen Biopharma; Treadwell Therapeutics; Zentalis
 
Emily L. Roberts-Thomson
Employment - Treadwell Therapeutics
Stock and Other Ownership Interests - AstraZeneca; BioNTech (I); Gilead Sciences (I); Moderna Therapeutics (I); Roche; Seagen (I); Treadwell Therapeutics; Vertex (I)
 
Trisha Denny
Employment - Treadwell Therapeutics
Stock and Other Ownership Interests - Treadwell Therapeutics
 
David W. Cescon
Consulting or Advisory Role - AstraZeneca; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Merck; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Inivata (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Patent (US62/675,228) for methods of treating cancers characterized by a high expression level of spindle and kinetochore associated complex subunit 3 (ska3) gene.